Sangamo Therapeutics Inc (GBY.MU)
Munich - Munich Delayed price. Currency in EUR
Add to watchlist
As of 08:03AM CEST. Market open.
Loading interactive chart…
- Zacks
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates
Sangamo (SGMO) delivered earnings and revenue surprises of -22.73% and 94.35%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
RICHMOND, Calif., May 09, 2024--SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FIRST QUARTER 2024 FINANCIAL RESULTS
- Business Wire
Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing
RICHMOND, Calif., May 09, 2024--Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing
© 2024 Yahoo. All rights reserved.